Looking beyond workforce parity: addressing gender inequity in pathology.

Female Humans Australia Gender Equity Sexism Workforce
Pathology gender gender bias gender stereotypes

Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 31 05 2023
revised: 17 07 2023
accepted: 18 07 2023
medline: 12 9 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

While women pathologists have made up over one-third of pathologists in the Australian workforce for over 15 years and at least 50% since 2019, they are under-represented in senior leadership roles, scientific publications, grant recipients, editorial boards, key presentations, and professional awards. This is not unique to pathology and is seen in the broader medical and academic community. Barriers to gender equity and equality in pathology, medicine and academia include gender stereotypes, gender-based discrimination, structural and organisational barriers as well as broader social and cultural barriers. A diverse leadership reflective of the whole professional body and the broader community is important for optimal health outcomes. It is the responsibility and moral duty of individuals and organisations to address any gender disparities, inequities, and inequalities by monitoring, identifying, and acting on gender biases and systemic barriers that hinder appropriate levels of representation by women.

Identifiants

DOI: 10.1016/j.pathol.2023.07.002 PMID: 37573162
pubmed: 37573162
pii: S0031-3025(23)00177-0
doi: 10.1016/j.pathol.2023.07.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

760-771

Informations de copyright

Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.

Auteurs

Catriona A McKenzie (CA)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia. Electronic address: catriona.mckenzie@health.nsw.gov.au.

Ruta Gupta (R)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Louise Jackett (L)

Austin Health Pathology, Melbourne, Vic, Australia.

Lyndal Anderson (L)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Vivien Chen (V)

Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Department of Haematology Concord Repatriation and General Hospital, Sydney, NSW, Australia.

Jane E Dahlstrom (JE)

ACT Pathology Canberra Health Services, Canberra, ACT, Australia; Australian National University, Canberra, ACT, Australia.

Michael Dray (M)

Waikato DHB Laboratory, Hamilton, New Zealand.

Gelareh Farshid (G)

SA Pathology, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia.

Chris Hemmings (C)

Department of Anatomic Pathology Canterbury Health Laboratories, Christchurch, New Zealand; Department of Pathology and Biomedical Science University of Otago, Christchurch, New Zealand.

Rooshdiya Karim (R)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

James G Kench (JG)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Sonja Klebe (S)

SA Pathology, Adelaide, SA, Australia; Flinders University, Adelaide, SA, Australia.

Nicole Kramer (N)

Envoi Pathology, Brisbane, Qld, Australia.

Priyanthi Kumarasinghe (P)

PathWest, Perth, WA, Australia; Curtin Medical School, Perth, WA, Australia.

Fiona Maclean (F)

Douglass Hanly Moir Pathology Sonic Healthcare, Sydney, NSW, Australia; Macquarie University, Sydney, NSW, Australia.

Adrienne Morey (A)

ACT Pathology Canberra Health Services, Canberra, ACT, Australia; Australian National University, Canberra, ACT, Australia.

Minh Anh Nguyen (MA)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Sandra O'Toole (S)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; School of Medicine, University of Western Sydney, Sydney, NSW, Australia.

Beverley Rowbotham (B)

Sullivan Nicolaides Pathology, Brisbane, Qld, Australia; The University of Queensland, Brisbane, Qld, Australia.

Elizabeth L C Salisbury (ELC)

Sydney Medical School, University of Sydney, Sydney, NSW, Australia; School of Medicine, University of Western Sydney, Sydney, NSW, Australia; ICPMR Westmead Hospital, NSW Health Pathology, Westmead, NSW, Australia.

Richard A Scolyer (RA)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.

Katie Stewart (K)

Austin Health Pathology, Melbourne, Vic, Australia.

Lynette Waring (L)

Melbourne Pathology, Collingwood, Vic, Australia.

Caroline L Cooper (CL)

The University of Queensland, Brisbane, Qld, Australia; Pathology Queensland, Princess Alexandra Hospital, Brisbane, Qld, Australia.

Wendy A Cooper (WA)

Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; School of Medicine, University of Western Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Looking beyond workforce parity: addressing...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Looking beyond workforce parity: addressing...
questionsmedicales.fr › Sciences sociales › Sociologie › Équité de genre › Looking beyond workforce parity: addressing...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Prejugé › Sexisme › Looking beyond workforce parity: addressing...
questionsmedicales.fr › Administration des services de santé › Organisation et administration › Effectif › Looking beyond workforce parity: addressing...